Clinical Trials Browser

Phase 3 × Docosahexaenoic Acids × Thoracic × Clear all

NCT00243867 2025-08-01

Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer

Phase 3 Completed

518 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung